Scinai Immunotherapeutics Cash Flow Statement (2024-2025) | SCNI

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Dec2024	Dec2025
Operating Activities
Gains from Sales and Divestitures (Quarter)	0.02M	0.03M
Gains from Investment Securities (Quarter)	97.23M	510.43M
Non-cash Items (Quarter)	0.01M	0.01M